Soleno Therapeutics (SLNO) Assets (2013 - 2026)
Soleno Therapeutics (SLNO) reported Assets of $608.4 million for Q1 2026, up 91.26% year-over-year from $318.1 million in Q1 2025, and up 7.9% on a QoQ basis from $563.8 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Assets data on file, last reported at $608.4 million in Q1 2026.
- Quarterly Assets rose 91.26% year-over-year to $608.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $608.4 million (up 91.26% YoY) and the FY2025 annual result came in at $563.8 million, up 70.36% from the prior year.
- Assets improved to $608.4 million in Q1 2026 per SLNO's latest filing, from $563.8 million in the prior quarter.
- Across five years, Assets topped out at $608.4 million in Q1 2026 and bottomed at $19.5 million in Q1 2023.
- The 5-year median for Assets is $180.7 million (2023), against an average of $232.7 million.
- The widest annual swing landed in 2023, when Assets plunged 54.08%; it then jumped 882.84% in 2024.
- Tracing SLNO's Assets over 5 years: stood at $26.5 million in 2022, then jumped by 581.93% to $180.7 million in 2023, then soared by 83.17% to $331.0 million in 2024, then jumped by 70.36% to $563.8 million in 2025, then increased by 7.9% to $608.4 million in 2026.
- Per Business Quant, the three latest SLNO Assets figures stand at $608.4 million (Q1 2026), $563.8 million (Q4 2025), and $599.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 608.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 608.39 Mn |
| Dec 31, 2025 | 563.83 Mn |
| Sep 30, 2025 | 599.90 Mn |
| Jun 30, 2025 | 332.31 Mn |
| Mar 31, 2025 | 318.09 Mn |
| Dec 31, 2024 | 330.97 Mn |
| Sep 30, 2024 | 296.71 Mn |
| Jun 30, 2024 | 304.13 Mn |
| Mar 31, 2024 | 168.84 Mn |
| Dec 31, 2023 | 180.69 Mn |
| Sep 30, 2023 | 63.55 Mn |
| Jun 30, 2023 | 30.94 Mn |
| Mar 31, 2023 | 19.54 Mn |
| Dec 31, 2022 | 26.50 Mn |
| Sep 30, 2022 | 31.98 Mn |
| Jun 30, 2022 | 36.86 Mn |
| Mar 31, 2022 | 42.55 Mn |
| Dec 31, 2021 | 35.55 Mn |
| Sep 30, 2021 | 42.57 Mn |
| Jun 30, 2021 | 48.78 Mn |
| Mar 31, 2021 | 56.71 Mn |
| Dec 31, 2020 | 64.98 Mn |
| Sep 30, 2020 | 71.78 Mn |
| Jun 30, 2020 | 78.86 Mn |
| Mar 31, 2020 | 32.11 Mn |
| Dec 31, 2019 | 38.17 Mn |
| Sep 30, 2019 | 28.73 Mn |
| Jun 30, 2019 | 34.13 Mn |
| Mar 31, 2019 | 38.87 Mn |
| Dec 31, 2018 | 43.15 Mn |
| Sep 30, 2018 | 30.84 Mn |
| Jun 30, 2018 | 33.34 Mn |
| Mar 31, 2018 | 36.33 Mn |
| Dec 31, 2017 | 39.02 Mn |
| Sep 30, 2017 | 26.38 Mn |
| Jun 30, 2017 | 30.38 Mn |
| Mar 31, 2017 | 33.87 Mn |
| Dec 31, 2016 | 5.56 Mn |
| Sep 30, 2016 | 8.31 Mn |
| Jun 30, 2016 | 5.54 Mn |
| Mar 31, 2016 | 9.39 Mn |
| Dec 31, 2015 | 8.20 Mn |
| Sep 30, 2015 | 7.29 Mn |
| Jun 30, 2015 | 8.77 Mn |
| Mar 31, 2015 | 10.07 Mn |
| Dec 31, 2014 | 8.40 Mn |
| Sep 30, 2014 | 1.70 Mn |
| Dec 31, 2013 | 1.59 Mn |